Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.37 |
| ▸ | CPB1 | P15086 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11301850 | 1.00 | CPB2 (0.37) | CPB2CPB1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL60506 | 1.00 | CPB2 (0.37) | CPB2CPB1ALDH1A1CYP1A2CYP3A4 | |
| Fluoride SCHEMBL27998040 | 0.98 | CPB2 (0.36) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL10980804 | 0.98 | CPB2 (0.36) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL10981835 | 0.98 | CPB2 (0.36) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL10976751 | 0.98 | CPB2 (0.36) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL9186803 | 0.97 | CPB2 (0.36) | CPB2CPB1 | |
| SCHEMBL15665199 | 0.93 | CPB2 (0.36) | CPB2CPB1 | |
| SCHEMBL5984088 | 0.91 | TNF (0.41) | CPB2CPB1ALDH1A1 | |
| Tetrahydrofuran SCHEMBL10977306 | 0.90 | CPB2 (0.32) | CPB2CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117778530-A | Method for adding preset joint to 5' end of single-stranded DNA | 清华大学 | 2024-03-29 | — | — | CN | claimed |
| EP-3077008-B1 | BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS | HAN JIE (CN) | 2023-10-04 | — | — | EP | claimed |
| EP-2932981-B1 | Albumin-binding derivatives of GLP-1 | NOVO NORDISK AS (DK) | 2021-06-16 | — | — | EP | claimed |
| EP-3225631-B1 | DOUBLE-ACYLATED GLP-1 DERIVATIVES | NOVO NORDISK AS (DK) | 2019-01-09 | — | — | EP | claimed |
| EP-2190873-B1 | TRUNCATED GLP-1 DERIVATIVES AND THEIR THERAPEUTICAL USE | NOVO NORDISK AS (DK) | 2015-07-22 | — | — | EP | claimed |
| EP-2571897-B1 | NOVEL GLUCAGON LIKE PEPTIDE ANALOGS, COMPOSITION, AND METHOD OF USE | BETTA PHARMACEUTICALS CO LTD (CN) | 2014-11-05 | — | — | EP | claimed |
| EP-2007804-B1 | GLP-1 COMPOUNDS | AMGEN INC (US) | 2014-06-18 | — | — | EP | claimed |
| EP-2729481-A1 | ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION WITH REDUCED IMMUNOGENICITY | Amylin Pharmaceuticals, LLC (US) | 2014-05-14 | — | — | EP | claimed |
| WO-2013009545-A1 | ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION WITH REDUCED IMMUNOGENICITY | AMYLIN PHARMACEUTICALS, INC. (US) | 2013-01-17 | — | — | WO | claimed |
| EP-1605897-B1 | POLYETHELENE GLYCOL LINK GLP-1 COMPOUNDS | LILLY CO ELI (US) | 2012-07-25 | — | — | EP | claimed |
| EP-0812185-B1 | USE OF ANGIOGENESIS SUPPRESSORS FOR INHIBITING HAIR GROWTH | GILLETTE CO (US) | 2002-07-03 | — | — | EP | claimed |
| WO-2002046227-A2 | GLP-1 FUSION PROTEINS | ELI LILLY AND COMPANY (US) | 2002-06-13 | — | — | WO | claimed |
| WO-1998043658-A1 | GLUCAGON-LIKE PEPTIDE-1 ANALOGS | ELI LILLY AND COMPANY (US) | 1998-10-08 | — | — | WO | claimed |
| EP-0481675-B1 | Preparation of medicaments for treating asthma using (S)-alpha-fluoromethyl histidine and esters thereof | KOLLONITSCH JANOS DR (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0481675-A2 | Preparation of medicaments for treating asthma using (S)-alpha-fluoromethyl histidine and esters thereof | Kollonitsch, Janos, Dr. (US) | 1992-04-22 | — | — | EP | claimed |
| EP-0180597-B1 | COUGH/COLD MIXTURES COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | RICHARDSON-VICKS, INC. (US) | 1992-03-04 | — | — | EP | claimed |
| US-5030645-A | Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof | MERCK & CO., INC. (US) | 1991-07-09 | — | — | US | claimed |
| EP-0109036-B1 | ANTI-INFLAMMATORY/ANALGESIC COMBINATION OF ALPHA-FLUOROMETHYLHISTIDINE AND A SELECTED NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) | MERCK & CO. INC. (US) | 1987-09-02 | — | — | EP | claimed |
| EP-0046290-B1 | SYNERGISTIC COMBINATION OF (R,S)ALPHA-FLUOROMETHYLHISTIDINE AND CIMETIDINE AS AN ANTI-ULCER AGENT | MERCK & CO. INC. (US) | 1985-01-02 | — | — | EP | claimed |
| EP-0046290-A1 | Synergistic combination of (R,S)alpha-fluoromethylhistidine and cimetidine as an anti-ulcer agent | MERCK & CO. INC. (US) | 1982-02-24 | — | — | EP | claimed |